AstraZeneca Sues Watson Over Generic Pulmicort
AstraZeneca PLC filed a patent infringement suit against Watson Laboratories Inc. on Thursday in New Jersey, aiming to stop it from selling a generic form of asthma drug Pulmicort Respules....To view the full article, register now.
Already a subscriber? Click here to view full article